SCHEMBL20653129

SCHEMBL20653129

CC(C)n1c(=O)[nH]c(=O)c2c1nc(-c1cccnc1OCC1CC1)n2Cc1ccc(F)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ USP1 O94782 4/20 0.36
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ THRB P10828 1/20 0.35
▸ FFAR4 Q5NUL3 2/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.35
▸ P2RX7 Q99572 2/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652960 0.92 TP53 (0.42) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20652748 0.91 ALDH1A1 (0.40) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20652772 0.91 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20653050 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20652967 0.89 ALDH1A1 (0.45) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20653055 0.89 MDM2 (0.44) ALDH1A1KDM4EMEN1KMT2AHTT
SCHEMBL20656057 0.84 ALOX5AP (0.36) USP1ALOX5APFEN1FFAR4PTGDR2
SCHEMBL20652798 0.83 TRPC4 (0.38) USP1ALOX5APFEN1FFAR4PTGDR2
SCHEMBL20656195 0.78 TRPC4 (0.38) USP1ALOX5APFEN1FFAR4MDM2
SCHEMBL20653046 0.75 KDM4E (0.49) ALDH1A1KDM4EMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 ALDH1A1 1347/4885KDM4E 3884/4885MEN1 4272/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 ALDH1A1 1488/4885KDM4E 3789/4885MEN1 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback